Elicio Therapeutics Inc.

NASDAQ:ELTX USA Biotechnology

Market Cap

$210.21 Million

Market Cap Rank

#16655 Global

#6393 in USA

Share Price

$12.18

Change (1 day)

+0.16%

52-Week Range

$4.76 - $13.84

All Time High

$257.40

Elicio Therapeutics Inc. - Asset Resilience Ratio

Latest as of March 2022: 22.84%

Elicio Therapeutics Inc. (ELTX) has an Asset Resilience Ratio of 22.84% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$18.56 Million

Cash + Short-term Investments

Total Assets

$81.26 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Elicio Therapeutics Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Elicio Therapeutics Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$18.56 Million	22.84%
Total Liquid Assets	$18.56 Million	22.84%

Asset Resilience Insights

Good Liquidity Position: Elicio Therapeutics Inc. maintains a healthy 22.84% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.